Recurrent epithelioid malignant peripheral nerve sheath tumor with neurofibromatosis type 1: A case report and literature review

• Published in: Experimental and therapeutic medicine Vol. 18; no. 3; pp. 3072 - 3080
• Main Authors: Du, Peng, Zhu, Jia, Zhang, Zhen-Dong, He, Chong, Ye, Mei-Yu, Liu, Ya-Xiong, Tian, Qiu-Hong, Zeng, Jin-Sheng
• Format: Journal Article
• Language: English
• Published: Greece Spandidos Publications 01.09.2019; Spandidos Publications UK Ltd; D.A. Spandidos
• Subjects: Abdomen; Antigens; Brain cancer; Cancer metastasis; Case reports; China; Comparative analysis; Family medical history; Genetic disorders; Health aspects; Medical diagnosis; Medical prognosis; Melanoma; Metastasis; Mortality; Neurofibromatosis; Neurological disorders; NMR; Nuclear magnetic resonance; Oncology; Patients; Recurrence (Disease); Sarcoma; Skin cancer; Surgery; Tumors; China; neurofibromatosis type 1; differential diagnosis; epithelioid malignant peripheral nerve sheath tumor; prognosis; recurrent
• ISSN: 1792-1074; 1792-0981; 1792-1082
• DOI: 10.3892/ol.2019.10676

Malignant peripheral nerve sheath tumors (MPNSTs) are unusual and aggressive malignant soft-tissue tumors that comprise 5-10% of all soft-tissue sarcomas. Approximately 50% of MPNST cases are associated with neurofibromatosis type-1 (NF-1). As a rare MPNST subset, the epithelioid variant of MPNST (eMPNST) is histologically characterized by the predominant presence of epithelioid tumor cells, and accounts for <5% of all MPNSTs. In addition, eMPNST is rarely associated with NF-1 when compared with conventional MPNST. Although extensive clinicopathological studies have been conducted on eMPNST, clinicians face difficulty when attempting to make an accurate diagnosis. Subsequently, the biological consequences, including recurrence, metastasis and mortality rate in patients with eMPNST remain unclear. The current study presents the case of a 71-year-old woman with eMPNST and a family history of NF-1 in whom tumors had recurred twice on the lower back. A literature search for eMPNSTs was conducted by browsing PubMed and MEDLINE for English-language articles, as well as references from review articles, and revealed 129 published cases. Only 5 cases of eMPNST were associated with NF-1. The studies were retrospectively reviewed and the clinicopathological data of the patients, including tumor site, treatment, follow-up, prognosis, and immunohistochemical positivity were collected.